companydata.dkcompanydata.dk

EJLIFS BESLAGSMEDIE ApS: Financial statements 2023

CVR: 29772991

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

EJLIFS BESLAGSMEDIE ApS (CVR 29772991) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 215,509 and a net result of DKK 8,213 compared with DKK -93,712 the year before. That is an increase of 26.5% compared with the year before. Equity in the 2023 report amounted to DKK 130,900. The solvency ratio was 35.6%. The company had 1 employee in the financial year.

Gross Profit
DKK 215,509
Profit/Loss
DKK 8,213
Equity
DKK 130,900
Total Assets
DKK 367,261
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-216K8K131K1
2022-170K-94K123K1
2021-300K-37K216K-
2020676K445K64K308K-
2019603K320K-5K244K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

EJLIFS BESLAGSMEDIE ApS: The 2022 annual report is outJun 22, 2023

EJLIFS BESLAGSMEDIE ApS has published its annual report for 2022. Gross profit came to DKK 170,379, and the net result was DKK -93,712.

About EJLIFS BESLAGSMEDIE ApS

EJLIFS BESLAGSMEDIE ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2006. The company is registered under the industry Støtteaktiviteter i forbindelse med husdyravl. The company was previously named CLINICAL RESEARCH FOCUS ApS and VICH 8995 ApS. The management consists of Ejlif Schmidt-Petersen. The company is owned by Ejlif Schmidt-Petersen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 37,588 and a net result of DKK -105,303 compared with DKK -48,785 the year before. Equity in the 2025 report amounted to DKK -23,188.

Source: annual report 2025, Danish Business Authority